John T. Powers

2.6k total citations
16 papers, 927 citations indexed

About

John T. Powers is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, John T. Powers has authored 16 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in John T. Powers's work include Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Neuroblastoma Research and Treatments (3 papers). John T. Powers is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Neuroblastoma Research and Treatments (3 papers). John T. Powers collaborates with scholars based in United States, China and France. John T. Powers's co-authors include D. Gale Johnson, George Q. Daley, Pamela M. Rogers, Robert J. Rounbehler, Raju V. Pusapati, Marc T. Seligson, Erik S. Knudsen, Christopher N. Mayhew, Mark J. McArthur and Mingshan Yan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

John T. Powers

16 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John T. Powers United States	12	765	328	304	83	63	16	927
Andrea Prodosmo Italy	17	730 1.0×	148 0.5×	538 1.8×	38 0.5×	72 1.1×	18	923
Anja Deutzmann United States	9	608 0.8×	189 0.6×	230 0.8×	24 0.3×	143 2.3×	15	860
Nurten Yigit Belgium	15	577 0.8×	282 0.9×	264 0.9×	343 4.1×	53 0.8×	29	864
Rebecca D. Dodd United States	18	472 0.6×	169 0.5×	194 0.6×	162 2.0×	67 1.1×	40	897
Nobuaki Akakura United States	7	328 0.4×	311 0.9×	154 0.5×	22 0.3×	76 1.2×	9	596
Danny A. Zwijnenburg Netherlands	17	641 0.8×	303 0.9×	234 0.8×	337 4.1×	54 0.9×	23	965
Amit J. Sabnis United States	13	562 0.7×	113 0.3×	245 0.8×	54 0.7×	101 1.6×	32	951
Juliet Williams United States	6	484 0.6×	127 0.4×	260 0.9×	30 0.4×	34 0.5×	14	707
Clare M. Adams United States	16	641 0.8×	225 0.7×	244 0.8×	16 0.2×	102 1.6×	26	858
Nancy Wainman Canada	18	686 0.9×	79 0.2×	296 1.0×	50 0.6×	54 0.9×	26	944

Countries citing papers authored by John T. Powers

Since Specialization

Citations

This map shows the geographic impact of John T. Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Powers more than expected).

Fields of papers citing papers by John T. Powers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Powers. The network helps show where John T. Powers may publish in the future.

Co-authorship network of co-authors of John T. Powers

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Powers. A scholar is included among the top collaborators of John T. Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Powers. John T. Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hsieh, Meng-Hsiung, Yonglong Wei, Lin Li, et al.. (2024). Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins. Journal of Clinical Investigation. 134(15). 4 indexed citations

Sheeter, Dennis A., et al.. (2024). Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by MYCN and Tumor Suppressor microRNAs in Neuroblastoma. Cancers. 16(8). 1590–1590. 1 indexed citations

Tao, Ting, Hui Shi, Luca Mariani, et al.. (2020). LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors. Proceedings of the National Academy of Sciences. 117(28). 16516–16526. 31 indexed citations

Powers, John T., Kaloyan M. Tsanov, Daniel S. Pearson, et al.. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature. 535(7611). 246–251. 138 indexed citations

Tsanov, Kaloyan M., Daniel S. Pearson, Zhaoting Wu, et al.. (2016). LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. Nature Cell Biology. 19(1). 60–67. 55 indexed citations

Manier, Salomon, John T. Powers, Antonio Sacco, et al.. (2016). The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma. Leukemia. 31(4). 853–860. 67 indexed citations

Nguyen, Liem H., Daisy A. Robinton, Marc T. Seligson, et al.. (2014). Lin28b Is Sufficient to Drive Liver Cancer and Necessary for Its Maintenance in Murine Models. Cancer Cell. 26(2). 248–261. 157 indexed citations

Unternaehrer, Juli, Rui Zhao, Kitai Kim, et al.. (2014). The Epithelial-Mesenchymal Transition Factor SNAIL Paradoxically Enhances Reprogramming. Stem Cell Reports. 3(5). 691–698. 66 indexed citations

Manier, Salomon, John T. Powers, Antonio Sacco, et al.. (2013). Lin28B/Let-7 Axis Regulates Multiple Myeloma Proliferation By Enhancing c-Myc and Ras Survival Pathways. Blood. 122(21). 273–273. 3 indexed citations

10.

Jones, Matthew R., Matthew T. Blahna, Joseph D. Ferrari, et al.. (2012). Zcchc11 Uridylates Mature miRNAs to Enhance Neonatal IGF-1 Expression, Growth, and Survival. PLoS Genetics. 8(11). e1003105–e1003105. 47 indexed citations

11.

Azam, Mohammad, John T. Powers, William S. Einhorn, et al.. (2009). AP24163 Inhibits the Gatekeeper Mutant of BCR‐ABL and Suppresses In vitro Resistance. Chemical Biology & Drug Design. 75(2). 223–227. 18 indexed citations

12.

Powers, John T., Mohammad Azam, Nathanael S. Gray, & George Q. Daley. (2007). Dissection of Bcr-abl Structural Domains Relating to Kinase Auto-Inhibition Using a Forward Mutational Screen with the Non-ATP Competitive Inhibitor GNF-2.. Blood. 110(11). 1021–1021. 2 indexed citations

13.

Hong, Sungki, Raju V. Pusapati, John T. Powers, & D. Gale Johnson. (2006). Oncogenes and the DNA Damage Response: Myc and E2F1 Engage the ATM Signaling Pathway to Activate p53 and Induce Apoptosis. Cell Cycle. 5(8). 801–803. 37 indexed citations

14.

Pusapati, Raju V., Robert J. Rounbehler, John T. Powers, et al.. (2006). ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proceedings of the National Academy of Sciences. 103(5). 1446–1451. 122 indexed citations

15.

Powers, John T., et al.. (2004). E2F1 Uses the ATM Signaling Pathway to Induce p53 and Chk2 Phosphorylation and Apoptosis. Molecular Cancer Research. 2(4). 203–214. 117 indexed citations

16.

Russell, Jamie L., John T. Powers, Robert J. Rounbehler, et al.. (2002). ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc. Molecular and Cellular Biology. 22(5). 1360–1368. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact